Key result
Among the 4 exchangeable APOCs, elevated APOC3 predicts incident cardiovascular and kidney disease in type 1 diabetes and drives atherosclerosis by slowing triglyceride-rich lipoprotein clearance.
Answers are grounded in this paper and cite their sources.
Reveals how APOC3 drives atherosclerosis and kidney disease in diabetes, highlighting exchangeable apolipoproteins as key regulators of lipid metabolism.
APOA1 and APOB are the structural proteins of high-density lipoprotein and APOB-containing lipoproteins, such as low-density lipoprotein and very low-density lipoprotein, respectively. The 4 smaller APOCs (APOC1, APOC2, APOC3, and APOC4) are exchangeable apolipoproteins; they are readily transferred among high-density lipoproteins and APOB-containing lipoproteins. The APOCs regulate plasma triglyceride and cholesterol levels by modulating substrate availability and activities of enzymes interacting with lipoproteins and by interfering with APOB-containing lipoprotein uptake through hepatic receptors. Of the 4 APOCs, APOC3 has been best studied in relation to diabetes. Elevated serum APOC3 levels predict incident cardiovascular disease and progression of kidney disease in people with type 1 diabetes. Insulin suppresses APOC3 levels, and accordingly, elevated APOC3 levels associate with insulin deficiency and insulin resistance. Mechanistic studies in a mouse model of type 1 diabetes have demonstrated that APOC3 acts in the causal pathway of diabetes-accelerated atherosclerosis. The mechanism is likely due to the ability of APOC3 to slow the clearance of triglyceride-rich lipoproteins and their remnants, thereby causing an increased accumulation of atherogenic lipoprotein remnants in lesions of atherosclerosis. Less is known about the roles of APOC1, APOC2, and APOC4 in diabetes.
No takes yet. Share an insight, caveat, or question.
Hsu et al. (2023) conducted a review in Diabetes and diabetes-accelerated atherosclerosis. APOC apolipoproteins (APOC1, APOC2, APOC3, APOC4) was evaluated on Incident cardiovascular disease, kidney disease progression, and diabetes-accelerated atherosclerosis. Among the 4 exchangeable APOCs, elevated APOC3 predicts incident cardiovascular and kidney disease in type 1 diabetes and drives atherosclerosis by slowing triglyceride-rich lipoprotein clearance.
Synapse has enriched 10 related papers. Consider them for comparative context: